Oxadiazolyl pyrazolo-pyrimidines as mGluR2 antagonists

Details for Australian Patent Application No. 2006298829 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Woltering, Thomas Johannes; Wichmann, Juergen; Gatti McArthur, Silvia; Goetschi, Erwin

Agent Spruson & Ferguson

Pub. Number AU-B-2006298829 (Modified Examination)

PCT Pub. Number WO2007/039439

Priority 05108910.0 27.09.05 EP

Filing date 18 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 3 March 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039439 Priority application(s): WO2007/039439

22 May 2008 Alteration of Name

  The name of the applicant has been altered to F. Hoffmann-La Roche AG

3 March 2011 Application Accepted

  Published as AU-B-2006298829 (Modified Examination)

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298842-Water dispersible composition and method for preparing same

2006298828-Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists